Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. [Advances in the diagnosis and management of transplant-associated thrombotic microangiopathy].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2021
   Article
2. Risk factors for transplant-associated thrombotic microangiopathy and mortality in a pediatric cohort.Blood advances · 2020
   Article
3. Plasma levels of complement activation fragments C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation.Annals of hematology · 2017
   Article
4. In vitro evidence of complement activation in transplantation-associated thrombotic microangiopathy.Blood advances · 2017
   Article
5. Acute kidney injury in HCT: an update.Bone marrow transplantation · 2016
   Review
6. Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.Blood · 2013
   Article
7. Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?Transfusion · 2013
   Article
8. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Bone marrow transplantation · 2011
   Article
9. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes.American journal of hematology · 2010
   Article

Corrections and comments

• Comment on
  Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?2007

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as